Stock investors of Central Pharmaceuticals have been unsettled after the auditor of the listed drug maker issued an adverse opinion, warning of significant uncertainty over the company’s ability to ...
TCS has shared the schedule for the announcement of its Q3 FY26 earnings report. Along with the results, the IT major is also ...
In the report, Fauzia Haque FCA, Partner at FAMES & R, Chartered Accountants, highlighted multiple accounting irregularities, financial weaknesses, and instances of non-compliance with applicable laws ...
Pentagon's eighth consecutive failure, with this year's Department of Defense Agency Financial Report highlighting a range of weaknesses. The post Pentagon's failed audit obscures how taxpayer dollars ...
PharmAla Biotech Holdings Inc. ("PharmAla" or the "Company") (CSE: MDMA) (OTC: MDXXF), a biotechnology company focused on the research, development, and manufacturing ...